The current strategic change must be accompanied by significant personnel change. The new CEO must then secure a 'big pharma' partner and/or set the company up for sale at a fair price. Stubbings, French, Francis, West and the resident PR Manager have been abject failures. I have suspicions French had already knocked back deals that he thought were not in the best interests of shareholders yet we can see what the market thinks of the decisions that have been made.
The company was locked in conference calls all Friday and I will be calling first thing tomorrow.
The current strategic change must be accompanied by significant...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)